Murraya paniculata for anti-breast cancer activity- A Molecular docking and dynamics simulation approaches
preprint
OA: closed
AI-generated summary
Murraya paniculata extracts contain polyphenols and flavonoids with antioxidant activity, and 5,7-Dimethoxy-8-(2-oxo-3-methylbutyl) coumarin showed strong binding to the human estrogen receptor in molecular docking and dynamics simulations, indicating potential anti-breast cancer properties.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The Murraya paniculata ’s methanolic extracts were subjected to LC/MS analysis, a NO assay for measuring antioxidant activity, and an estimate of significant phytochemicals. Compared to the conventional ascorbic acid, abundant polyphenols, flavonoids, and tannins exhibit good antioxidant activity (50.88 % ) (53.87 % ). The LC/MS analysis further confirms the principal 13 active phytochemicals in the crude extract. These compounds were molecularly docked on the human estrogen receptor (a target protein for breast cancer) to identify the most powerful phytochemicals. In this investigation, the 5,7-Dimethoxy-8-(2-oxo-3-methylbutyl) coumarin exhibits good drug-like qualities and a greater binding interaction (-30.3502 Kcal/mol) than the conventional 5-fluorouracil (-25.3186 Kcal/mol). We also use molecular dynamics modeling to confirm this phytochemical’s protein stability, RMSD, and RMSF with the target. Finally, we discovered seven phytochemicals with powerful anti-breast cancer properties.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00